Reduced hcv recurrent viremia in people who inject drugs (pwid) after treatment induced hcv cure

Arshia Alimohammadi., Arpreet Singh., Tyler Raycraft., Rajvir Shahi., Ghazaleh Kiani1 and Brian Conway

We evaluated the risk of recurrent viremia in active PWID after achieving a sustained virologic response as a result of treatment in a multidisciplinary care facility, with enhanced long-term follow-up. Rates of recurrent viremia in this setting were lower compared to when treatment was implanted in a traditional clinical setting - highlighting the efficacy of this model.

Download PDF: